Inhalant abuse with inhalant-induced psychotic disorder, unspecified
ICD-10 F18.159 is a billable code used to indicate a diagnosis of inhalant abuse with inhalant-induced psychotic disorder, unspecified.
Inhalant abuse refers to the intentional inhalation of volatile substances to achieve psychoactive effects. This behavior can lead to significant psychological and physical health issues, including inhalant-induced psychotic disorder. Symptoms may include hallucinations, delusions, and disorganized thinking, which can severely impair functioning. The psychotic disorder is a direct result of inhalant use, and its severity can vary based on the frequency and amount of inhalants consumed. Diagnosis typically requires a thorough clinical assessment, including a detailed history of substance use and mental health evaluation. Treatment often involves a combination of detoxification, counseling, and behavioral therapies aimed at addressing both the substance use disorder and the associated psychotic symptoms. Given the potential for acute and chronic health consequences, early intervention is crucial for improving outcomes.
Detailed mental health assessments, including history of substance use and current symptoms.
Patients presenting with acute psychosis following inhalant use.
Need for collaboration with addiction specialists for comprehensive care.
Thorough documentation of substance use patterns and treatment plans.
Patients in detoxification programs exhibiting psychotic symptoms.
Focus on integrated treatment approaches addressing both addiction and mental health.
Used during initial evaluation of a patient with inhalant abuse.
Comprehensive assessment of substance use and mental health status.
Psychiatric evaluation should include substance use history.
Symptoms may include hallucinations, delusions, disorganized thinking, and significant impairment in functioning. These symptoms arise directly from inhalant use and can vary in severity.
